AB 8939
Alternative Names: AB-8939Latest Information Update: 29 Apr 2025
At a glance
- Originator AB Science
- Class Antineoplastics; Imidazolidines; Oxazoles; Small molecules
- Mechanism of Action Aldehyde dehydrogenase inhibitors; Apoptosis stimulants; Tubulin polymerisation inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Phase I/II Acute myeloid leukaemia